In Utero Delivery of Targeted Ionizable Lipid Nanoparticles Facilitates In Vivo Gene Editing of Hematopoietic Stem Cells

To facilitate the delivery of gene editing cargo to fetal HSCs, scientists developed an ionizable lipid nanoparticle platform targeting the CD45 receptor on the surface of HSCs.